Pulmonary Drug Delivery Systems Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2017 – 2025

Chapter 1       Executive Summary

Chapter 2       Global Pulmonary Drug Delivery Systems Market: An Overview

2.1          Report Description and Research Scope

2.2          Research Methodology

2.2.1      Primary Research

2.2.2      Secondary Research and Internal DataModeling

2.3          Analyst Credentials

Chapter 3       Major Players of the Global Pulmonary Drug Delivery Systems Market

3.1            Overview

3.2            Present and Forecast Competitive Scenario (2018 Vs 2025)

3.3            Global Pulmonary Drug Delivery Systems Market: Company Share Analysis

Chapter 4       Market Outline

4.1          Market Trend, Outlook and Forecast

4.2          Market Dynamics

4.2.1      Drivers

4.2.1.1  Impact Analysis

4.2.2      Restraints

4.2.2.1  Impact Analysis

4.2.3      Opportunities

4.3          Porter’s Five Forces Analysis

Chapter 5       Market byDisease Area: Size and Forecast, 2016 – 2025

5.1          Overview

5.2          Asthma

5.2.1      Current Trend and Analysis

5.2.2      Market Size and Forecast

5.3          Chronic Obstructive Pulmonary Disease (COPD)

5.3.1      Current Trend and Analysis

5.3.2      Market Size and Forecast

5.4          Other Diseases

5.4.1      Current Trend and Analysis

5.4.2      Market Size and Forecast

Chapter 6   Market by Region/ Geography: Market Size and Forecast, 2016 – 2025

6.1          Overview

6.2          North America

6.2.1      Current Trend and Analysis

6.2.2      Market Size and Forecast

6.2.3      Regional Market Dynamics

6.2.3.1  Drivers

6.2.3.2  Restraints

6.2.3.3  Opportunities

6.2.4      U.S.

6.2.4.1  Market Size and Forecast

6.2.5      Canada

6.2.5.1  Market Size and Forecast

6.2.6      Mexico

6.2.6.1  Market Size and Forecast

6.3          Europe

6.3.1      Current Trend and Analysis

6.3.2      Market Size and Forecast

6.3.3      Regional Market Dynamics

6.3.3.1  rivers

6.3.3.2  Restraints

6.3.3.3  Opportunities

6.3.4      Rest of Europe

6.3.4.1  Market Size and Forecast

6.4          Asia-Pacific

6.4.1      Current Trend and Analysis

6.4.2      Market Size and Forecast

6.4.3      Regional Market Dynamics

6.4.3.1  Drivers

6.4.3.2  Restraints

6.4.3.3  Opportunities

6.4.4      Rest of Asia-Pacific

6.4.4.1  Market Size and Forecast

6.5          Rest of the World (RoW)

6.5.1      Current Trend and Analysis

6.5.2      Market Size and Forecast

6.5.3      Regional Market Dynamics

6.5.3.1  Drivers

6.5.3.2  Restraints

6.5.3.3  Opportunities

Chapter 7   Company Profiles

7.1          3M Pharmaceuticals, Inc.

7.2          AstrazenecaPlc

7.3          BoehringerIngelheimGmbh

7.4          Cipla, Inc.

7.5          Dr. Reddy's Laboratories Ltd.

7.6          GlaxosmithklinePlc

7.7          Koninklijke Philips N.V. (Respironics, Inc.)

7.8          Lupin, Limited

7.9          Mylan N.V.

7.10       Novartis Ag

7.11       Omron Corporation

7.12       Pfizer, Inc.

7.13       Pulmatrix, Inc.

7.14       Teva Pharmaceutical Industries, Ltd.

7.15       Vectura Group Plc